If you read the listing rule that the company cited (7.1a) you'll get a better understanding. Basically every company is entitled to raise 10% without shareholder approval. The additional 15% which requires shareholder approval is only available to companies with a sub $300m market cap and cannot be included in the ASX300. In my opinion I believe the company are using the opportunity of the currently low valuation to access additional placement capacity for the purpose of future acquisitions. Acquiring businesses in T2 and or T3 would make it easier to expand in those regions.
I do believe the company is currently undervalued and I think we're going to get a bit of a surprise to the upside at the next 4C
- Forums
- ASX - By Stock
- $1 Club
If you read the listing rule that the company cited (7.1a)...
Featured News
Add OVT (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.2¢ |
Change
-0.010(23.2%) |
Mkt cap ! $73.08M |
Open | High | Low | Value | Volume |
4.3¢ | 4.4¢ | 3.1¢ | $5.445M | 147.9M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 410000 | 3.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.2¢ | 603749 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 674516 | 0.031 |
30 | 3112841 | 0.030 |
9 | 2010931 | 0.029 |
10 | 1875392 | 0.028 |
6 | 1365874 | 0.027 |
Price($) | Vol. | No. |
---|---|---|
0.032 | 853749 | 9 |
0.033 | 793406 | 8 |
0.034 | 1024867 | 6 |
0.035 | 3686222 | 10 |
0.036 | 4535734 | 13 |
Last trade - 11.58am 13/11/2024 (20 minute delay) ? |
Featured News
OVT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online